Author

Sara Bendinelli

Observed names: Bendinelli Sara, S Bendinelli, S. Bendinelli

Institution: Roche (Italy)

Observed institutions: University of Pisa, Roche (Italy)

OpenAlex ID: A5090101393

Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor

2013 · Barbara Costa, Sara Bendinelli, et al. · PLoS ONE · 79

PDF

Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma

2010 · P. Gabelloni, E. Da Pozzo, et al. · Neuroscience · 56

Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein

2012 · Sabrina Castellano, Sabrina Taliani, et al. · Journal of Medicinal Chemistry · 44

Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors

2011 · Elisa Nuti, Francesca Casalini, et al. · European Journal of Medicinal Chemistry · 37

Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review

2023 · Pier Mannuccio Mannucci, Craig M. Kessler, et al. · Haemophilia · 25

PDF

TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance

2014 · Barbara Costa, Eleonora Da Pozzo, et al. · APOPTOSIS · 25

Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization

2010 · Sabrina Taliani, Eleonora Da Pozzo, et al. · Journal of Medicinal Chemistry · 25

Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein

2011 · Barbara Cosimelli, Francesca Simorini, et al. · European Journal of Medicinal Chemistry · 15

Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors—A Multicenter, Observational Italian Study with a Wearable Device

2024 · Maria Elisa Mancuso, Chiara Biasoli, et al. · Journal of Clinical Medicine · 8

Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes

2012 · Eleonora Da Pozzo, Maria Chiara Barsotti, et al. · Thrombosis Research · 7

Drugs Don't Work in Patients Who Don't Take Them: Dr. Drin, The New ICT Paradigm For Chronic Therapies

2013 · Brondi Raffaello, Bannò Filippo, et al. · Studies in health technology and informatics · 5

Inhibition of Metalloproteinases Derived from Tumors: New Insights in the Treatment of Human Glioblastoma

2010 · S Bendinelli, P Gabelloni, et al. · 2

Physical Activity, Bleedings and Quality of Life in Patients with Haemophilia a without Inhibitors - a Multicenter, Observational Italian Study with a Wearable Device

2023 · Maria Elisa Mancuso, Chiara Biasoli, et al. · Blood · 1

Physical Activity, Bleeding Incidence and Health‐Related Quality of Life, in Patients With Haemophilia A Without Inhibitors, Treated With Emicizumab: A Post‐Hoc Descriptive Analysis of the Power Study Data

2026 · Matteo Nicola Dario Di Minno, Berardino Pollio, et al. · Haemophilia

PDF

PB3364 Real-World use of a Novel Outcome Indicator Reflecting Patient Perspectives to Support Value-Based Healthcare Decision-Making in Haemophilia A in Italy: the HemPROve Non-Interventional Study

2026 · Giancarlo Castaman, Cristina Santoro, et al. · Research and Practice in Thrombosis and Haemostasis

PDF

EE617 An Italian Pharmacoutilization Analysis in Patients With Hemophilia A With and Without Inhibitors After Switching to Emicizumab

2024 · V Perrone, M Leogrande, et al. · Value in Health

PDF

Real-world clinical and psychosocial outcomes among people with mild or moderate haemophilia A treated on-demand in the Italian CHESS II cohort: a real-world data analysis

2024 · Giancarlo Castaman, Maria Elisa Mancuso, et al. · The Journal of Haemophilia Practice

PDF

EE96 Resource Consumption Analysis in Patients with Hemophilia A Without Inhibitors on Prophylaxis with FVIII Before Switching to Emicizumab

2023 · E. Giacomini, M. Leogrande, et al. · Value in Health

Blood inflammatory markers in motor neuron disease patients: pattern changes over time along disease progression

2017 · Paolo Bongioanni, Cristina Dolciotti, et al. · CINECA IRIS Institutial research information system (University of Pisa)

Glioblastoma multiforme: antitumoral in vitro effect by induction of collapse of mitochondrial membrane potential

2012 · Claudia Martini, Barbara Costa, et al. · CINECA IRIS Institutial research information system (University of Pisa)

Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells

2012 · Barbara Costa, Eleonora Da Pozzo, et al. · CINECA IRIS Institutial research information system (University of Pisa)

New Approaches in the Treatment of Glioblastoma Using a Low Dosage of Matrix-metalloproteinase Inhibitors

2010 · Claudia Martini, S Bendinelli, et al. · CINECA IRIS Institutial research information system (University of Pisa)

Nanomolar Concentration of Metalloproteinase-3 Inhibitor Protects Human Dopaminergic Cells Against Oxidative Stress

2010 · P Gabelloni, S Bendinelli, et al.

New Insights in the treatment of human glioblastoma: inhibition of metalloproteinases in vitro activity and cellular invasiveness

2010 · Claudia Martini, S Bendinelli, et al. · CINECA IRIS Institutial research information system (University of Pisa)

Inhibition of Metalloproteinases in Vitro Activity and Arrest of Invasion in Human Glioblastoma Cells

2010 · P Gabelloni, S Bendinelli, et al.

Works count: 37

Citation count: 329

H-index: 8

I10-index: 8